Drugmaker Wyeth this morning said it has acquired a private British biotech company developing medicines in the potentially lucrative field of obesity, in a deal that could be worth up to $150 million ...
NEW YORK] Novartis agreed to buy biotechnology company Avidity Biosciences in a deal that values it at US$12 billion, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback